510(k) Report

510(k) · Cleared

Cleared

AcQMap High Resolution Imaging and Mapping System

K210680510(k) TraditionalCleared Aug 5, 2021150-day reviewClass II21 CFR 870.1425

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Acutus Medical, Inc. · DQK Computer, Diagnostic, Programmable

Cleared on Aug 5, 2021 as substantially equivalent to K193013 (Acutus Medical, Inc., 2020) after a 150-day review. Its family tree reaches back 10 generations to 1992.

Decided
Aug 5, 2021
Review
150 days
Class
Class II
Product code
DQK
Recalls
None
Predicates
1

Its longest line of descent runs back 10 generations to K921750 (1992). 16 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 10 generations backK921750 Cvis Insight Iii SystemCardiovascular Imaging Systems, Inc. · 1992
  2. 6 generations between
  3. 3 generations backK190131 AcQMap High Resolution Imaging and Mapping SystemAcutus Medical, Inc. · 2019
  4. 2 generations backK191392 AcQMap High Resolution Imaging and Mapping SystemAcutus Medical, Inc. · 2019
  5. 1 generation backK193013 AcQMap High Resolution Imaging and Mapping SystemAcutus Medical, Inc. · 2020
  6. This deviceK210680 AcQMap High Resolution Imaging and Mapping SystemAcutus Medical, Inc. · 2021
Show all 10 generations
  1. Root · 10 generations backK921750 Cvis Insight Iii SystemCardiovascular Imaging Systems, Inc. · 1992
  2. 9 generations backK980851 Galaxy Intravascular Ultrasound System, Model I5028Boston Scientific Corp · 1998
  3. 8 generations backK051679 Ilab Ultrasound Imaging SystemBoston Scientific Corp · 2005 · Recalled
  4. 7 generations backK072517 Ilab Ultrasound Imaging System, Version 1.3Boston Scientific Corp · 2007 · Recalled
  5. 6 generations backK123535 Ilab Ultrasound Imaging SystemBoston Scientific Corp · 2013
  6. 5 generations backK130243 Ilab Ultrasound Imaging SystemBoston Scientific Corp · 2013
  7. 4 generations backK170948 AcQMap High Resolution Imaging and Mapping SystemAcutus Medical, Inc. · 2017
  8. 3 generations backK190131 AcQMap High Resolution Imaging and Mapping SystemAcutus Medical, Inc. · 2019
  9. 2 generations backK191392 AcQMap High Resolution Imaging and Mapping SystemAcutus Medical, Inc. · 2019
  10. 1 generation backK193013 AcQMap High Resolution Imaging and Mapping SystemAcutus Medical, Inc. · 2020
  11. This deviceK210680 AcQMap High Resolution Imaging and Mapping SystemAcutus Medical, Inc. · 2021
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−10K921750Cvis Insight Iii SystemCardiovascular Imaging Systems, Inc.1992—
−9K980851Galaxy Intravascular Ultrasound System, Model I5028Boston Scientific Corp1998—
−8K051679Ilab Ultrasound Imaging SystemBoston Scientific Corp20052
−7K072517Ilab Ultrasound Imaging System, Version 1.3Boston Scientific Corp20071
−6K123535Ilab Ultrasound Imaging SystemBoston Scientific Corp2013—
−5K130243Ilab Ultrasound Imaging SystemBoston Scientific Corp2013—
−4K170948AcQMap High Resolution Imaging and Mapping SystemAcutus Medical, Inc.2017—
−3K190131AcQMap High Resolution Imaging and Mapping SystemAcutus Medical, Inc.2019—
−2K191392AcQMap High Resolution Imaging and Mapping SystemAcutus Medical, Inc.2019—
−1K193013AcQMap High Resolution Imaging and Mapping SystemAcutus Medical, Inc.2020—
0 (this device)K210680AcQMap High Resolution Imaging and Mapping SystemAcutus Medical, Inc.2021—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199320
201020
201110
201310
FIG. 1 — Lineage of K210680, 1992–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DQK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQK device

  1. #1 K213682 HemoSphere Advanced Monitor, HemoSphere…score 26.7 · 28 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K193013AcQMap High Resolution Imaging and Mapping System
Summary page 4
…ce Manufacturer FDA 510(k) AcQMap High Resolution Imaging and Mapping System, Acutus Medical, Inc. K193013 Model 900100 510(K) SUMMARY Page 1 of 11 =…
Acutus Medical, Inc.2020—

Also cleared against K193013: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 29 years and passes through 3 companies; a new generation was cleared every 2.2 years on median.
  • 2 of the 16 ancestors have a recall of any class.
  • 1 other device also cites its predicate K193013.

How does its category compare?

All DQK devices

DQK Computer, Diagnostic, Programmable: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · DQK

23so far in 2026, the most since 2007

2007: 132008: 42009: 122010: 92011: 122012: 72013: 132014: 92015: 72016: 152017: 72018: 142019: 152020: 162021: 162022: 192023: 212024: 132025: 222026 (partial year): 23
2007high 23 (2026) · low 4 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQK

95in 2025

2007: 83 days median2008: 70 days median2009: 93 days median2010: 64 days median2011: 69 days median2012: 74 days median2013: 68 days median2014: 90 days median2015: 125 days median2016: 190 days median2017: 146 days median2018: 150 days median2019: 113 days median2020: 123 days median2021: 132 days median2022: 136 days median2023: 133 days median2024: 100 days median2025: 95 days median2026 (partial year): 151 days median
2007high 190 (2016) · low 64 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQK

1in 2025

2007: 42008: 12009: 22010: 32011: 22012: 32013: 12014: 42015: 22017: 22018: 62019: 12020: 12021: 12022: 22023: 22024: 242025: 12026 (partial year): 2
2007high 24 (2024) · low 0 (2016)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DQK

433in 2025

2007: 182008: 342009: 402010: 492011: 552012: 1292013: 1802014: 1152015: 1312016: 3402017: 2522018: 2612019: 2182020: 2152021: 3512022: 3192023: 3402024: 5572025: 433
2007high 557 (2024) · low 18 (2007)2025

MAUDE reports naming product code DQK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071383418
2008470134
20091293240
2010964349
20111269255
20127743129
201313681180
20149904115
201571252131
2016151900340
201771462252
2018141506261
2019151131218
2020161231215
2021161321351
2022191362319
2023211332340
20241310024557
202522951433
2026231512—

What is it indicated for?

The AcQMap System is intended for use in patients for whom electrophysiology procedures have been prescribed. When used with the AcQMap Catheters, the AcQMap System is intended to be used to reconstruct the selected chamber from ultrasound data for purposes of visualizing the chamber anatomy and displaying electrical impulses as either charge density-based or voltage-based maps of complex arrhythmias that may be difficult to identify using conventional…

Read the full statement (124 words)

The AcQMap System is intended for use in patients for whom electrophysiology procedures have been prescribed.

When used with the AcQMap Catheters, the AcQMap System is intended to be used to reconstruct the selected chamber from ultrasound data for purposes of visualizing the chamber anatomy and displaying electrical impulses as either charge density-based or voltage-based maps of complex arrhythmias that may be difficult to identify using conventional mapping systems alone.

AND

When used with the specified Patient Electrodes, the AcQMap System is intended to display the position of AcQMap Catheters and conventional electrophysiology (EP) catheters in the heart.

OR

When used with conventional electrophysiology catheters, the AcQMap System provides information about the electrical activity of the heart and about catheter location during the procedure.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K210680: AcQMap High Resolution Imaging and Mapping System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K210680

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026